The neurobiology of retinoic acid in affective disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 315-331

  Bremner, J Douglas ^a,b   McCaffery, Peter ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Depressive disorders; Frontal cortex; Hippocampus; Isotretinoin; Retinoids; Vitamin A

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETRETIN; GLUCOCORTICOID RECEPTOR; HYPNOTIC SEDATIVE AGENT; INTERFERON; ISOTRETINOIN; MINOCYCLINE; PSYCHOSTIMULANT AGENT; RESERPINE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOL; THYROID HORMONE RECEPTOR;

ACNE; AGGRESSION; ANOREXIA; ATAXIA; BEHAVIOR CHANGE; BRAIN PSEUDOTUMOR; BRAIN REGION; CLINICAL TRIAL; DEPRESSION; DIPLOPIA; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG MEGADOSE; DRUG WITHDRAWAL; FATIGUE; HALLUCINATION; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; IRRITABILITY; LEARNING DISORDER; LOW DRUG DOSE; MEMORY DISORDER; MOOD DISORDER; NAUSEA; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; PAPILLEDEMA; PARANOIA; PSYCHOSIS; REVIEW; SELF CONCEPT; SIDE EFFECT; SIGNAL TRANSDUCTION; SPEECH DISORDER; SUICIDE; TERATOGENICITY; VOMITING; WEAKNESS;

ADULT; ANIMALS; BRAIN; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; ISOTRETINOIN; MICE; MOOD DISORDERS; NEUROTRANSMITTER AGENTS; PREFRONTAL CORTEX; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; SUICIDE; TRETINOIN;

EID: 38849157849     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.07.001     Document Type: Review

References (236)

1. Alemayehu W. Pseudotumor cerebri (toxic effect of the "magic bullet"). Ethiop Med J 33 (1995) 265-270
2. Alvarez-Buylla A., and Lim D.A. For the long run: maintaining germinal niches in the adult brain. Neuron 41 (2004) 683-686
3. APA. DSM-IV-TR: diagnostic and statistical manual of mental disorders (2000), American Psychiatric Press, Washington, D.C.
4. Arican O., Sasmaz S., and Ozbulut O. Increased suicidal tendency in a case of psoriasis vulgaris under acitretin treatment. J Eur Acad Dermatol Venereol 20 (2006) 464
5. Asson-Batres M.A., Zeng M.S., Savchenko V., Aderoju A., and McKanna J. Vitamin A deficiency leads to increased cell proliferation in olfactory epithelium of mature rats. J Neurobiol 54 (2003) 539-554
6. Austin M.P., Dougall N., Ross M., Murray C., O'Carroll R.E., Moffoot A., et al. Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 26 (1992) 31-43
7. Australian Adverse Drug Reactions Committee: Depression with isotretinoin. Aust Advers Drug React Bull 17 (1998)
8. Australian Adverse Drug Reactions Committee. Acne, isotretinoin, and suicidality. Aust Advers Drug React Bull 24 (2005)
9. Azoulay L., Blais L., and Berard A. Isotretinoin and the risk of depression in patients with acne: a case-crossover study. Pharmacoepidemiol Drug Saf 15 (2006) S261
10. Barak Y., Wohl Y., Greenberg Y., Bar Dayan Y., Friedman T., Shoval G., et al. Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol 20 (2005) 39-41
11. Bass M.H. The relation of Vitamin A intake to cerebrospinal fluid pressure: a review. J Mt Sinai Hosp N Y 26 (1959) 421-423
12. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
13. Baxter L.R., Phelps M.E., Mazziotta J.C., Schwartz J.M., Gerner R.H., Selin C.E., et al. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 42 (1985) 441-447
14. Bechara A., Damasio A.R., Damasio H., and Anderson S.W. Insensitivity to future consequences following damage to prefrontal cortex. Cognition 50 (1994) 7-15
15. Bench C.J., Dolan R.J., Friston K.J., and Frackowiak R.S.J. Positron emission tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders. Br J Psychiatry 157 (1990) 82-95
16. Bench C.J., Friston K.J., Brown R.G., Scott L.C., Frackowiak R.S.J., and Dolan R.J. The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med 22 (1992) 607-615
17. Bench C.J., Frackowiak R.S.J., and Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25 (1995) 247-251
18. Bendich A., and Langseth L. Safety of Vitamin A. Am J Clin Nutr 49 (1989) 358-371
19. Benkelfat C., Bradwejn J., Meyer E., Ellenbogen M., Milot S., Gjedde A., et al. Functional neuroanatomy of CCK sub 4-induced anxiety in normal healthy volunteers. Am J Psychiatry 152 (1995) 1180-1184
20. Berlin H.A., Rolls E.T., and Kischka U. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 127 (2004) 1108-1126
21. Bigby M., and Stern R.S. Adverse reactions to isotretinoin. J Am Acad Dermatol 18 (1988) 543-552
22. Biver F., Goldman S., Delvenne V., Luxen A., De Maertelaer V., Hubain P., et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 36 (1994) 381-388
23. Blaner W.S. Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol 45 (2001) S129-S135
24. Blomhoff R. Introduction: overview of Vitamin A metabolism and function. In: Blomhoff R. (Ed). Vitamin A in health and disease (1994), Marcel Dekker, New York 1-35
25. Blumenthal J.A., Bayak M.A., and Moore K.A. Effects of exercise training on older patients with major depression. Arch Intern Med 159 (1999) 2349-2356
26. Bowden C., Theodorou A.E., Cheetham S.C., Lowther S., Katona C.L., Crompton M.R., et al. Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 752 (1997) 227-233
27. Bravard P., Krug M., and Rzeznick J.C. Isotretinoine et depression: soyons vigilants. Nouv Dermatol 12 (1993) 215
28. Bremner J.D. Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectr 7 (2002) 129-139
29. Bremner J.D., Innis R.B., Salomon R.M., Staib L., Ng C.K., Miller H.L., et al. PET measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54 (1997) 364-374
30. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H., and Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 157 (2000) 115-117
31. Bremner J.D., Vythilingam M., Vermetten E., Nazeer A., Adil J., Khan S., et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 51 (2002) 273-279
32. Bremner J.D., Vythilingam M., Ng C.K., Vermetten E., Nazeer A., Oren D., et al. Regional brain metabolic correlates of positron emission tomographic measurement of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289 (2003) 3125-3134
33. Bremner J.D., Vythilingam M., Vermetten E., Vaccarino L.V., and Charney D.S. Deficits in hippocampal and anterior cingulate function during verbal declarative memory encoding in mid-life depression. Am J Psychiatry 161 (2004) 637-645
34. Bremner J.D., Fani N., Ashraf A., Votaw J.R., Brummer M.E., Cummins T., et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry 162 (2005) 983-991
35. Bruno N.P., Beacham B.E., and Burnett J.W. Adverse effects of isotretinoin therapy. Cutis 33 (1984) 484-489
36. Buchsbaum M.S., DeLisi L.E., Holcomb H., Cappelletti J., King A.C., Johnson J., et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41 (1984) 1159-1166
37. Buchsbaum M.S., DeLisi L.E., Holcomb H., Kessler R.C., Johnson J., King A.C., et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [F-18] 2-deoxyglucose in affective illness. J Affect Disord 10 (1986) 137-152
38. Burket J.M., and Storrs F.J. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 123 (1987) 432-433
39. Byrne A., and Hnatko G. Depression associated with isotretinoin therapy [letter]. Can J Psychiatry 40 (1995) 567
40. Byrne A., and Hnatko G. Depression associated with isotretinoin therapy. Can J Psychiatry 40 (1995) 567
41. Byrne A., Costello M., Greene E., and Zibin T. Isotretinoin therapy and depression-evidence for an association. Ir J Psychosom Med 15 (1998) 58-60
42. Cassileth B.R., Lusk E.J., and Tenaglia A.N. A psychological comparison of patients with malignant melanoma and other dermatologic disorders. J Am Acad Dermatol 7 (1982) 742-746
43. CDC. Suicide rates vol. 2007 (2006)
44. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10 (1996) 940-954
45. Charest A., Wainer B.H., and Albert P.R. Cloning and differentiation induced expression of a murine serotonin 1A receptor in a septal cell line. J Neurosci 13 (1993) 5164-5171
46. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., and Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75 (2000) 1729-1734
47. Chia C.Y., Lane W., Chibnall J., Allen A., and Siegfried E. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne. Arch Dermatol 141 (2005) 557-560
48. Chiang M.Y., Misner D., Kempermann G., Schikorski T., Giguere V., Sucov H.M., et al. An essential role for retinoid receptors RAR beta and RXR gamma in long-term potentiation and depression. Neuron 21 (1998) 1353-1361
49. Coberly S., Lammer E., and Alashari M. Retinoic acid embryopathy: case report and review of literature. Pediatr Pathol Lab Med 16 (1996) 823-836
50. Cocco S., Diaz G., Stancampiano R., Diana A., Carta M., Curreli R., et al. Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience 115 (2002) 475-582
51. Colbert M.C., Linney E., and LaMantia A.S. Local sources of retinoic acid coincide with retinoid-mediated transgene activity during embryonic development. Proc Natl Acad Sci U S A 90 (1993) 6572-6576
52. Corcoran J., and Maden M. Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nat Neurosci 2 (1999) 307-308
53. Cott A.D., and Wisner K.L. Isotretinoin treatment of a woman with bipolar disorder. J Clin Psychiatry 60 (1999) 407-408
54. Cotterill J.A., and Cunliff W.J. Suicide in dermatological patients. Br J Dermatol 137 (1997) 246-250
55. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
56. Crandall J., Sakai Y., Zhang J., Koul O., Mineur Y., Crusio W.E., et al. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci U S A 101 (2004) 5111-5116
57. Cunliff W.J., van der Kerkhof P.C.M., Caputo R., Caicchini S., Cooper A., Fyrand O.L., et al. Roaccutane treatment guidelines: results of an international survey. Pharm Treatment 194 (1997) 351-357
58. Damasio H., Grabowski T., Frank R., Galaburda A.M., and Damasio A.R. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 264 (1994) 1102-1105
59. Danish medicines agencies: Psychic adverse reactions to the use of the acne medication isotretinoin (2002), DKMA
60. Delgado P.L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 61 (2000) S7-S11
61. Diehl D.J., and Gershon S. The role of dopamine in mood disorders. Compr Psychiatry 33 (1992) 115-120
62. Dolan R.J., and Friston K.J. Positron emission tomography in psychiatric and neuropsychiatric disorders. Semin Neurol 9 (1989) 330-337
63. Drevets W.C., and Raichle M.E. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 28 (1992) 261-274
64. Drevets W.C., Price J.L., Simpson J.R.J., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
65. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord 4 (2002) 183-194
66. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 267 (2000) 4315-4324
67. Duke E.E., and Guenther L. Psychiatric reactions to the retinoids. Can J Dermatol 5 (1993) 467
68. Duman R.S. Depression: a case of neuronal life and death?. Biol Psychiatry 56 (2004) 140-145
69. Eaton W.W., Kramer M., Anthony J.C., Dryman A., Shapiro S., and Locke B.Z. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 79 (1989) 163-178
70. Eckhoff C., and Nau H. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 31 (1990) 1445-1454
71. Etchamendy N., Enderlin V., Marighetto A., Vouimba R.M., Pallet V., Jaffard R., et al. Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci 21 (2001) 6423-6429
72. Etchamendy N., Enderlin V., Marighetto A., Pallet V., Higueret P., and Jaffard R. Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res 145 (2003) 37-49
73. Ferahbas A., Turan M.T., Esel E., Utas S., Kutlugun C., and Kilic C.G. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatolog Treat 15 (2004) 153-157
74. Ferguson S.A., Cisneros F.J., Goug B.J., and Ali S.F. Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female Sprague-Dawley rats. Food Chem Toxicol 43 (2005) 1289-1296
75. Ferguson S.A., Cisneros F.J., Gough B., Hanig J.P., and Berry K.J. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans- retinoic acid does not alter depression-like behaviors in rats. Toxicol Sci 87 (2005) 451-459
76. Fishbane S., Frei G.L., Finger M., Dressler R., and Silbiger S. Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis 25L (1995) 346-349
77. Fiskerstrand C.E., Lovejoy E.A., and Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458 (1999) 171-174
78. Food and drug administration center for drug evaluation and research: Meeting of the dermatologic and opthalmic drugs advisory committee (2000), Dermatologic and Opthalmic Drugs Advisory Committee, Washington, D.C. September 19
79. Friedman T., Wohl Y., Knobler H.Y., Lubin G., Brenner S., Levi Y., et al. Increased mental health services related to isotretinoin treatment: a 5-year analysis. Eur Neuropsychopharm 16 6 (2006) 413-416
80. Garcia R. Stress, metaplasticity, and antidepressants. Curr Mol Med 2 (2002) 629-638
81. Garrie S.A., and Garrie E.V. Anxiety and skin diseases. Cutis 22 (1978) 205-208
82. Gatti S., and Serri F. Acute depression from isotretinoin. J Am Acad Dermatol 25 (1991) 132
83. George M.S., Ketter T.A., and Post R.M. Prefrontal cortex dysfunction in clinical depression. Depression 2 (1994) 59-72
84. George M.S., Ketter T.A., Parekh P.I., Horwitz B., Herscovitch P., and Post R.M. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152 (1995) 341-351
85. Gerber A., Raab A.P., and Sobel A.E. Vitamin A poisoning in adults: with description of a case. Am J Med 16 (1954) 729-745
86. Gomber S., and Chellani H. Acute toxicity of vitamin A administered with measles vaccine. Indian Pediatr 33 (1996) 1053-1055
87. Goulden V., Layton A.M., and Cunliffe W.J. Current indications for isotretinoin as a treatment for acne vulgaris. Pharm Treatment 190 (1995) 284-287
88. Gupta M.A., Gupta A.K., Schork N.J., Ellis C.N., and Voorhees J.J. Psychiatric aspects of the treatment of mild to moderate facial acne: Some preliminary observations. Int J Dermatol 29 (1990) 719-721
89. Haupt R. Akute symptomatische psychose bei Vitamin A-Intoxikation. Nervenarzt 48 (1977) 91-95
90. Hazen P.G., Carney J.F., Walker A.E., and Stewart J.J. Depression-a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 9 (1983) 278-279
91. Henderson C.A., and Highet A.S. Depression induced by etrinate [letter]. Br Med J 298 (1989) 96
92. Henn F.A., and Vollmayr B. Neurogenesis and depression: etiology or epiphenomenon?. Biol Psychiatry 56 (2004) 146-150
93. Hepburn N.C. Deliberate self-poisoning with isotretinoin. Br J Dermatol 122 (1990) 840-841
94. Hersom K., Neary M.P., Levaux H.P., Klaskala W., and Strauss J.S. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol 49 (2003) 424-432
95. Hull P.R., and D'Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 4 (2003) 493-505
96. Hull P.R., and D'Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 4 (2004) 493-505
97. Hull P.R., and D'Arcy C. Acne, depression, and suicide. Dermatol Clin 23 (2005) 665-674
98. Hull P.R., and Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 4 (2000) 66-70
99. Hunter K., Maden M., Summerbell D., Eriksson U., and Holder N. Retinoic acid stimulates neurite outgrowth in the amphibian spinal cord. Proc Natl Acad Sci U S A 88 (1991) 3666-3670
100. Hurwitz T.A., Clark C., Murphy E., Klonoff H., Martin W.R.W., and Pate B.D. Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry 35 (1990) 684-688
101. Husson M., Enderlin V., Alfos S., Boucheron C., Pallet V., and Higueret P. Expression of neurogranin and neuromodulin is affected in the striatum of vitamin A-deprived rats. Brain Res Mol Brain Res 123 (2004) 7-17
102. Idres N., Marill J., Flexor M.A., and Chabot G.G. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 277 (2002) 31491-31498
103. International Union of Nutritional Sciences, Committee 1/I, Nomenclature: Generic descriptors and trivial names for vitamins and related compounds. Recommendations 1976. Nutritional Abstracts Review Series A 48 (1978) 831-835
104. Irish medicines board: drug safety newsletter (1998)
105. Isotretinoin and depression. Can Adverse Drug React Newsl 9 (1999)
106. Jacobs B.L. Adult brain neurogenesis and depression. Brain Behav Immun 16 (2002) 602-609
107. Jacobs D.G., Deutsch N., and Brewer M. Suicide, depression, and isotretinoin: is there a causal link?. J Am Acad Dermatol 45 (2001) S168
108. Jacobs S., Lie D.C., Decicco K.L., Shi Y., Deluca L.M., Gage F.H., et al. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci U S A 103 (2006) 3902-3907
109. Jay T.M., C.R., Hotte M., Naudon L., Gurden H., and Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotoxicol Res 6 (2004) 233-244
110. Jentsch J.D., Roth R.H., and Taylor J.R. Role for dopamine in the behavioral functions of the prefrontal cortico striatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res 126 (2000) 433-453
111. Jick S.S., Kremers H.M., and Vasilakis-Scaramozza C. Isotretinoin use and risk of depression: Psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 136 (2000) 1231-1236
112. Kane M.A., Chen N., Sparks S., and Napoli J.L. Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J 388 (2005) 363-369
113. Kastner P., Chambon P., and Leid M. Role of nuclear retinoic acid receptors in the regulation of gene expression. In: Blomhoff R. (Ed). Vitamin A in health and disease (1994), Marcel Dekker, New York
114. Kellett S.C., and Gawkrodger D.J. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol (1999) 273-282
115. Kempermann G. Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression. Bipolar Disord 4 (2002) 17-33
116. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 (1997) 493-495
117. Kempermann G., Kuhn H.G., and Gage F.H. Experience-induced neurogenesis in the senescent dentate gyrus. J Neurosci 18 (1998) 3206-3212
118. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
119. Krezel W., Ghyselinck N., Samad T.A., Dupe V., Kastner P., Borrelli E., et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279 (1998) 863-867
120. Krezel W., Kastner P., and Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89 (1999) 1291-1300
121. La Placa M. Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol 19 (2005) 380-399
122. Lacerda A.L.T., Keshavan M.S., Hardan A.Y., Yorbik O., Brambilla P., Sassi R.B., et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 55 (2004) 353-358
123. Lai T.J., Payne M.E., Byrum C.E., Steffens D., and Krishnan K.R. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 48 (2000) 971-975
124. Lammer E.J., and Armstrong D.L. Malformations of hindbrain structures among humans exposed to isotretinoin (13-cis-retinoic acid) during early embryogenesis. In: Morris-Kay G.M. (Ed). Retinoids in normal development and teratogenesis (1992), Oxford University Press, Oxford
125. Landy D. Pibloktoq (hysteria) and Inuit nutrition: possible implication of hypervitaminosis A. Soc Sci Med 21 (1985) 173-185
126. Lane R.D., Reiman E.M., Ahern C.E., Schwartz G.E., and Davidson R.J. Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry 154 (1997) 926-933
127. Lee S.H., Payne M.E., Steffens D.C., McQuoid D.R., Lai T.J., Provenzale J.M., et al. Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biol Psychiatry 54 (2003) 529-533
128. Lengqvist J., Mata de Urquiza A., Bergman A.C., Wilson T.M., Sjovall J., Perlmann T., et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 3 (2004) 692-703
129. Lindberg G., Bingefors K., Ranstam J., Rastam L., and Melander A. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. Br Med J 316 (1998) 741-745
130. Lindemayr H. Isotretinoin intoxication in attempted suicide. Acta Derm Venereol 66 (1986) 452-453
131. Lohnes D., Mark M., Mendelsohn C., Dolle P., Dierich A., Gorry P., et al. Function of the retinoic acid receptors (RAR) during development. (1) Craniofacial and skeletal abnormalities in RAR double mutants. Development 120 (1994) 2723-2748
132. Lombaert A., and Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. Eur Neurol 14 (1976) 340-350
133. Luo T., Wagner E., Crandall J.E., and Drager U.C. A retinoic-acid critical period in the early postnatal mouse brain. Biol Psychiatry 56 (2004) 971-980
134. Luo T., Wagner E., Grun F., and Drager U.C. Retinoic acid signaling in the brain marks formation of optic projections, maturation of the dorsal telencephalon, and function of limbic sites. J Comp Neurol 470 (2004) 297-316
135. Maden M. Role and distribution of retinoic acid during CNS development. Int Rev Cytol 209 (2001) 1-77
136. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
137. Marie J., and See G. Acute hypervitaminosis A of the infant. Its clinical manifestation with benign acute hydrocephaly and pronounced bulge of the fontanel. A clinical and biologic study. Am J Dis Child 73 (1954) 731-736
138. Marqueling A.L., and Zane L.T. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 24 (2005) 92-102
139. Martinot J.L., Hardy P., Feline A., Huret J.-D., Mazoyer B., Attar-Levy D., et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 147 (1990) 1313-1317
140. Mata De Urquiza A., Solomin L., and Perlmann T. Feedback-inducible nuclear-receptor-driven reporter gene expression in transgenic mice. Proc Natl Acad Sci U S A 96 (1999) 13270-13275
141. Matsuoka I., Kumagai M., and Kurihara K. Differential and coordinated regulation of expression of norepinephrine transporter in catecholaminergic cells in culture. Brain Res 776 (1997) 881-888
142. Mayberg H.S. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 6 (1994) 428-442
143. Mayberg H.S., Starkstein S.E., Sadzot B., Preziosi T., Andrezejewski P.L., Dannals R.F., et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's Disease. Ann Neurol 28 (1990) 57-64
144. Mayberg H.S., Starkstein S.E., Peyser C.E., Brandt J., Dannals R.F., and Folstein S.E. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 42 (1992) 1791
145. Mayberg H.S., Lewis P.J., Regenold W., and Wagner H.N. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 35 (1994) 929-934
146. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 (1997) 1057-1061
147. McCaffery P., and Drager U.C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci U S A 91 (1994) 7772-7776
148. McCaffery P.J., Adams J., Maden M., and Rosa-Molinar E. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 18 (2003) 457-472
149. McCaffery P., Zhang J., and Crandall J.E. Retinoic acid signaling and function in the adult hippocampus. J Neurobiol 66 (2006) 780-791
150. McCance-Katz E.F., and Price L.H. Depression associated with Vitamin A intoxication. Psychosomatics 33 (1992) 117
151. Medansky R.S., Handler R.M., and Medansky D.L. Self-evaluation of acne and emotion: a pilot study. Psychosomatics 22 (1981) 379-383
152. Mendelsohn C., Lohnes D., Decimo D., Lufkin T., LeMeur M., Chambon P., et al. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120 (1994) 2749-2771
153. Mervaala E., Fohr J., Konogen M., Valkonen-Korhonen M., Vainio P., Partanen J., et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 30 (2000) 117-125
154. Mey J., and McCaffery P. Retinoic acid signaling in the nervous system of adult vertebrates. Neuroscientist 10 (2004) 409-421
155. Meyskens F.L.J. Short clinical reports. J Am Acad Dermatol 6 (1982) 732-733
156. Middelkoop T. Roaccutane (Isotretinoin) and the risk of suicide: case report and a review of the literature and pharmacovigilance reports. J Pharm Pract 12 (1999) 374-378
157. Misner D.L., Jacobs S., Shimizu Y., de Urquiza A.M., Solomin L., Perlmann T., et al. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A 98 (2001) 11714-11719
158. Morgan C.A., and LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 109 (1995) 681-688
159. Morgan C.A., Romanski L.M., and LeDoux J.E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 163 (1993) 109-113
160. Neary M.P., Klaskala W., and McLane J. Epidemiological study of adverse events in Accutane users and matched non-users: retrospective analysis of major US health plan claims database. Pharmacoepidemiol Drug Saf 10 (2001) S141
161. Ng C.H., and Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry 37 (2003) 78-81
162. Ng C.H., Tam M.M., and Hook S.J. Acne, isotretinoin treatment and acute depression. World J Biol Psychiatry 2 (2001) 159-161
163. Ng C.H., Tam M.M., Celi E., Tate B., and Scheitzer I. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol 45 (2002) 262-268
164. O'Connell M.J., Chua R., Hoyos B., Buck J., Chen Y.Q., Derguini F., et al. Retro-retinoids in regulated cell growth and death. J Exp Med 184 (1996) 549-555
165. Oliver T.K., and Havener W.H. Eye manifestations of chronic Vitamin A intoxication. AMA Arch Ophthalmol 60 (1958) 19-22
166. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95 (1998) 13290-13295
167. O'Reilly K.C., Shumaker J., Gonzalez-Lima F., Lane M.A., and Bailey S.J. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology 31 (2006) 1919-1927
168. Orfanos C.E., Zouboulis C.C., Almond-Roesler B., and Geilen C.C. Current use and future potential role of retinoids in dermatology. Drugs 53 (1997) 358-384
169. Pasquariello P.S., Schut L., and Borns P. Benign increased intracranial hypertension due to chronic vitamin A overdosage in a 26-month-old child. Clin Pediatr 16 (1977) 379-382
170. Patten S.B., and Love E.J. Drug-induced depression. Incidence, avoidance and management. Drug Saf 10 (1994) 203-219
171. Peleg-Raibstein D., Pezze M.A., Ferger B., Zhang W.N., Murphy C.A., Feldon J., et al. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats. Neuroscience 132 (2005) 219-232
172. Rajkowska N.A., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Melzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1085-1098
173. Reiman E.M., Lane R.D., Ahern G.L., Schwartz G.E., Davidson R.J., Friston K.J., et al. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry 154 (1997) 918-925
174. Restak R.M. Pseudotumor cerebri, psychosis, and hypervitaminosis A. J Nerv Ment Dis 155 (1972) 155-172
175. Ring R.A., Bench C.J., Trimble M.R., Brooks D.J., Frackowiak R.S.J., and Dolan R.J. Depression in Parkinson's Disease: a positron emission study. Br J Psychiatry 165 (1994) 333-339
176. Robusto O. Depressao por antiacneico. Acta Med Port 15 (2002) 325-326
177. Rocher C., Spedding M., Munoz C., and Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 14 (2004) 224-229
178. Rodahl K., and Moore T. Vitamin A content and toxicity of bear and seal liver. Biochem J 37 (1943) 166-168
179. Ross S.A., and De Luca L.M. A new metabolite of retinol: all-trans-4-oxo-retinol as a receptor activator and differentiation agent. Nutr Rev 54 (1996) 355-356
180. Rossant J., Zirngibl R., Cado D., Shago M., and Giguère V. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev 5 (1991) 1333-1344
181. Rowe A. Retinoid X receptors. Int J Biochem Cell Biol 29 (1997) 275-278
182. Rubinow D.R., Peck G.L., Squillace K.M., and Gantt G.G. Reduced anxiety and depression in cystic acnes patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 17 (1987) 25-32
183. Sackeim H.A., Prohovnik I., Moeller J.R., Brown R.P., Apter S., Prudic J., et al. Regional cerebral blood flow in mood disorders, I: comparison of major depressives and normal controls at rest. Arch Gen Psychiatry 47 (1990) 60-70
184. Sakai Y., Crandall J.E., Brodsky J., and McCaffery P. 13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice. Ann N Y Acad Sci 1021 (2004) 436-440
185. Samad T.A., Krezel W., Chambon P., and Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci U S A 94 (1997) 14349-14354
186. Sani B.P., Venepally P.R., and Levin A.A. Didehydroretinoic acid: retinoid receptor-mediated transcriptional activation and binding properties. Biochem Pharmacol 53 (1997) 1049-1053
187. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
188. Sapolsky R.M. Stress and plasticity in the limbic system. Neurochem Res 28 (2003) 1735-1742
189. Scheinman P.L., Peck G.L., Rubinow D.R., DiGiovanna J.J., Abangan D.L., and Ravin P.D. Acute depression from isotretinoin. J Am Acad Dermatol 22 (1990) 1112-1114
190. Scott A.I.F., Dougall N., Ross M., O'Carroll R.E., Riddle W., Ebmeier K.P., et al. Short-term effects of electroconvulsive treatment on the uptake of [Tc-99m] exametazine into brain in major depression shown with single photon emission tomography. J Affect Disord 30 (1994) 27-34
191. Seigel N.J., and Spackman T.J. Chronic hypervitaminosis A with intracranial hypertension and low cerebrospinal fluid concentration of protein. Clin Pediatr 11 (1972) 580-584
192. Selhorst J.B., Waybright E.A., Jennings S., and Corbett J.J. Liver lover's headache: Pseudotumor cerebri and vitamin A intoxication. JAMA 252 (1984) 3365
193. Sharma R.P. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Schizophr Res 72 (2005) 79-90
194. Shaw E.W., and Niccoli J.Z. Hypervitaminosis A: report of a case in an adult male. Ann Intern Med 39 (1953) 131-134
195. Sheline Y.I. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54 (2003) 338-352
196. Sheline Y.I., Wang P., Gado M., Csernansky J., and Vannier M. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996) 3908-3913
197. Sheline Y.I., Sanhavi M., Mintun M.A., and Gado M.U. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19 (1999) 5034-5043
198. Shih T.W., Shealy Y.F., Strother D.L., and Hill D.L. Nonenzymatic isomerization of all-trans- and 13-cis-retinoids catalyzed by sulfhydryl groups. Drug Metab Dispos 14 (1986) 698-702
199. Shuster S., Fisher G.H., Harris E., and Binnel D. The effect of skin disease on self-image. Br J Dermatol 99 (1978) 18-19
200. Silva A.J. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J Neurobiol 54 (2003) 224-237
201. Spector R.H., and Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 34 (1984) 1509-1511
202. Sporn M.B., Roberts A.B., and Goodman D.S. The retinoids: biology, chemistry, and medicine (1994), Raven Press, New York
203. Steffens D.C., and Krishnan K.R.R. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 43 (1998) 705-712
204. Steffens D.C., Byrum C.E., McQuoid D.R., Greenburg D.L., Payne M.E., Blichington T.T., et al. Hippocampal volume in geriatric depression. Biol Psychiatry 48 (2000) 301-309
205. Stimson W.H. Vitamin A intoxication in adults: report of a case with a summary of the literature. N Engl J Med 265 (1961) 369-373
206. Stoll A.L., Severus E., Freeman M.P., Rueter S., Zboyan H.A., Diamond E., et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56 (1999) 407-412
207. Strom B.L. Pharmacoepidemiology. 4 ed. (2005), Wiley, New York
208. Tang G., and Russell R.M. Formation of all-trans-retinoic acid and 13-cis-retinoic acid from all-trans retinyl palmitate in humans. J Nutr Biochem 2 (1991)
209. Thompson Haskell G., Maynard T.M., Shatzmiller R.A., and Lamantia A.S. Retinoic acid signaling at sites of plasticity in the mature central nervous system. J Comp Neurol 452 (2002) 228-241
210. Toresson H., Mata de Urquiza A., Fagerstrom C., Perlmann T., and Campbell K.A. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development 126 (1999) 1317-1326
211. Toresson H., Mata de Urquiza A., Fagerstrom C., Perlmann T., and Campbell K.A. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development 126 (1999) 1317-1326
212. Tsukada M., Schroder M., Roos T.C., Chandraratna R.A., Reichert U., Merk H.F., et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol 115 (2000) 321-327
213. Vakili K., Pillay S.S., Lafer B., Fava M., Renshaw P.F., Bonello-Cintron C.M., et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 47 (2000) 1087-1090
214. Valdenaire O., Maus-Moatti M., Vincent J.D., Mallet J., and Vernier P. Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. J Neurochem 71 (1998) 929-936
215. Van der Meeren H.L.M., van der Schaar W.W., and van den Hurk C.M.A.M. The psychological impact of severe acne. Cutis 7 (1985) 84-86
216. van Praag H., Kempermann G., and Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 2 (1999) 266-270
217. Villalobos D., Ellis M., and Snodgrass W.R. Isotretinoin (Accutane)-associated psychosis. Vet Hum Toxicol 31 (1989) 362
218. Vincent S.L., Khan Y., and Benes F.M. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 19 (1995) 112-120
219. Wagner E., Luo T., and Drager U.C. Retinoic acid synthesis in the postnatal mouse brain marks distinct developmental stages and functional systems. Cereb Cortex 12 (2002) 1244-1253
220. Waclaw R.R., Wang B., and Campbell K.A. The homeobox gene Gsh2 is required for retinoid production in the embryonic mouse telencephalon. Development 131 (2004) 4013-4020
221. Wagner E., Luo T., Sakai Y., Parada L.F., Drager U.C., and Radttonpipcc E.J.N.J. Retinoic acid delineates the topography of neuronal plasticity in postnatal cerebral cortex. Eur J Neurosci 24 (2006) 329-340
222. Wang H.F., and Liu F.C. Regulation of multiple dopamine signal transduction molecules by retinoids in the developing striatum. Neuroscience 134 (2005) 97-105
223. Wang T.W., Zhang H., and Parent J.M. Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development 132 (2005) 2721-2732
224. Weigan U.-W., and Chou R.C. Pharmacokinetics of oral isotretinoin. J Am Acad Dermatol 39 (1998) S8-S12
225. Wilson D.A., Best A.R., and Sullivan R.M. Plasticity in the olfactory system: lessons for the neurobiology of memory. Neuroscientist 10 (2004) 513-524
226. Wolf G. Vitamin A functions in the regulation of the dopaminergic system in the brain and pituitary gland. Nutr Rev 56 (1998) 354-355
227. Wolf G. The visual cycle of the cone photoreceptors of the retina. Nutr Rev 62 (2004) 283-286
228. Wooltorton E. Accutane (isotretinoin) and psychiatric adverse effects. Can Med Assoc J 168 (2003) 66
229. Wu G., Fang Y., Lu Z.H., and Ledeen R.W. Induction of axon-like and dendrite-like processes in neuroblastoma cells. J Neurocytol 27 (1998) 1-14
230. Wysowski D.K., Pitts M., and Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 45 (2001) 515-519
231. Wysowski D.K., Pitts M., and Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med 344 (2001) 460
232. Zetterstrom R.H., Simon A., Giacobini M.M.J., Ericksson U., and Olson L. Localization of cellular retinoid-binding proteins suggests specific roles for retinoids in the adult central nervous system. Neuroscience 62 (1994) 899-918
233. Zetterström R.H., Tomac A., Eriksdotter-Nilsson M., Nennesmo I., Eriksson U., and Olson L. Localization of retinoid-binding proteins and retinoid receptors suggests a function for retinoic acid in developing and adult dopamine-innervated brain areas. Soc Neurosci Abstr 20 (1994) 1688
234. Zetterstrom R.H., Lindqvist E., Mata de Urquiza A., Tomac A., Eriksson U., Perlmann T., et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11 (1999) 407-416
235. Zhang J., Smith D., Yamamoto M., Ma L., and McCaffery P. The meninges is a source of retinoic acid for the late-developing hindbrain. J Neurosci 23 (2003) 7610-7620
236. (2000b): http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3639b1c_05.pdf, Vol 2005.